Manejo anestésico del craneofaringioma infantil

Craniopharyngioma counts for 5 to 10% of intracranial tumors in children and is the third most common tumour in childhood. Craniopharyngioma can cause endocrine abnormalities such as hypothyroidism, somatropin deficiency, corticotropin deficiency and diabetes insipidus (in 90% of cases appears 2-3 days after surgery) and also present anesthetic implications such as cardiovascular disorders and airway management. Multidisciplinary management should be performed in these settings, to avoid endocrine complications and acid-base disorders. Here, the role of the anesthesiologist is vital to provide adequate patient care, minimizing risks and complications of the disease during the perioperative stage.